Popular Articles

Angiotech Pharmaceuticals Announces Launch Of Quill SRS Product Codes For Laparoscopic Gynecology Procedures
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced the launch of a series of new, proprietary Quill(TM) SRS product codes specifically designed for laparoscopic, or minimally invasive, gynecology procedures, including hysterectomies and myomectomies. In 2008, there were approximately 750,000 hysterectomies performed in the United States of which approximately 130,000 were performed laparoscopically. In addition, there were approximately 72,000 myomectomies performed in the United States to remove uterine fibroid tumors. Management estimates 6-8% annual growth in laparoscopically assisted hysterectomies through 2014.
buy viagra
New Diagnostic Method For Gout: Dual Energy Computed Tomography Instead Of Joint Aspiration
The most reliable method of diagnosing gout is to aspirate the joint in order to obtain fluid to verify the presence of monosodium urate crystals (uric acid). Up to now, computed tomography (CT) has played a limited role in the evaluation of gout, since conventional CT systems cannot reliably verify deposits of uric acid. However, a current study at the Vancouver General Hospital in Canada gives rise to speculation that dual-energy computed tomography (DECT) could radically change the diagnosis of this disease. DECT enables fast, noninvasive examinations and, based on initial evaluations, has the potential to surpass the invasive gold standard and clinical examination in terms of reliability. Investigations have confirmed the high sensitivity of the DECT method in detecting uric acid deposits. The Canadian scientists used the SOMATOM Definition computed tomography (CT scanner) from Siemens for their investigation. This system is the only CT scanner worldwide that features two X-ray tubes capable of simultaneously producing different energies.
News of the day
Sixteen States, DOJ Join Whistle-Blower Lawsuits Alleging Wyeth Defrauded Medicaid Programs
The U.S. Department of Justice and 16 states have joined two whistle-blower lawsuits filed in federal District Court in Massachusetts alleging that Wyeth defrauded the government by not offering the same discounts on two medications to Medicaid that it offered to hospitals, the Wall Street Journal reports. The lawsuits were initiated following a grand-jury investigation by the U.S. Attorney"s Office in Massachusetts (Johnson, Wall Street Journal, 5/19). The other states included in the lawsuits are California, Delaware, Florida, Illinois, Indiana, Louisiana, New York, Michigan, Nevada, New Hampshire, Tennessee, Texas, Virginia, Wisconsin and the District of Columbia (Barrett, AP/Austin American-Statesman, 5/18).According to the lawsuits, Wyeth from 2000 to 2006 sold hospitals a bundled package called the Protonix Performance Agreement, which included its acid-reflux drugs Protonix Oral and Protonix IV. The suits allege that Wyeth gave hospitals up to a 94% discount for the oral version under the deal, with the understanding that when patients were released from hospitals they would be switched from the intravenous version of the drug to the oral version. According to the complaint, Wyeth hoped to gain an edge in a competitive market for acid-reflux pills by taking advantage of its standing as the only company offering an IV acid-reflux drug. The Journal reports that Wyeth charged hospitals $20 per vial for the IV version of Protonix and $3 for the oral version.Medicaid rules stipulate that the program is entitled to the lowest price on prescription drugs, and drugmakers are required to pay states rebates if they offer discounts to any other entities. The lawsuits state that Wyeth avoided paying hundreds of millions of dollars to state Medicaid programs because it did not offer the programs the same discounts or provide rebates (Wall Street Journal, 5/19).The lawsuits are seeking financial penalties against Wyeth of up to three times the amount lost by Medicaid. Assistant Attorney General Tony West said, "By offering massive discounts to hospitals, but then hiding that information from the Medicaid program, we believe Wyeth caused Medicaid programs throughout the country to pay much more for these drugs than they should have." Wyeth spokesperson Doug Petkus said that Wyeth "believes that its pricing calculations were correct and intends to defend itself vigorously in these actions" (AP/Austin American-Statesman, 5/18).
Nutrition

Indiana U. Expert Says Nation's Physicians Support National Health Insurance

President Barack Obama spoke to the American Medical Association (AMA) recently addressing concerns about health insurance reform and the whole nation, including physicians from coast to coast, listened. "A general consensus seems to exist that the AMA will not support a public health insurance, option. Since the AMA bills itself as "the voice of physicians," by taking an anti-public insurance stance, the AMA is fostering the notion that a majority of physicians would be against comprehensive health care reform, including a public option. But our research indicates that on this issue, the AMA is not speaking for physicians," said Aaron Carroll, M.D., on Monday in response to Obama"s speech at the AMA. Dr. Carroll is director of the Indiana University Center for Health Policy and Professionalism (CHPPR), associate professor of pediatrics at the IU School of Medicine and a pediatrician at Riley Hospital for Children. A study conducted by CHPPR at the Indiana University School of Medicine and published last year in the Annals of Internal Medicine found that 59 percent of physicians would support government legislation for National Health Insurance, a much more radical type of reform than that proposed by the Obama administration. Only 32 percent of physicians opposed national health insurance, according to the study. The CHPPR survey of 2,200 physicians showed a 10 percent increase in support for national health insurance from a previous survey. Nearly every medical specialty showed an increase in levels of support for national health insurance. With the exception of radiologists, anesthesiologists and surgical subspecialists, a majority of every medical specialty now support national health insurance, according to the study. "While the AMA may oppose a public insurance option, there is no evidence that physicians do," said Dr. Carroll, a health services researcher who is a Regenstrief Institute affiliated scientist. Cindy Fox Aisen Indiana University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):